Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sensory Adaptation Training vs Escitalopram in IBS-C
NCT00584571Phase 2Completed
- Sponsor
- Augusta University
- Start
- Dec 2007
- Primary completion
- Dec 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial of Escitalopram oxalate oral solution in irritable bowel syndrome (IBS) and rectal hypersensitivity (RH) (2 arms), sponsored by Augusta University. Primary endpoints: Rectal Sensory Thresholds at 3 months and Abdominal Pain at 3 months. Started Dec 2007; status: completed.
02
Drugs
Escitalopram oxalate oral solution
03
Conditions
irritable bowel syndrome (IBS)rectal hypersensitivity (RH)
Beyond the preview
Go deeper on NCT00584571.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00584571.